Fischetti Gary P
SEC Form 4 insider trading activity
Fischetti Gary P has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Fischetti Gary P is listed as Director at Anika Therapeutics, Inc. Inside the rolling window, Fischetti Gary P reported 2 open-market purchases totaling $41K in ANIK and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,000 ANIK shares on Aug 3, 2026, worth $21K.
Companies traded
Other insiders at ANIK
Insider Buying
$41K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Fischetti Gary P made?
Fischetti Gary P has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Fischetti Gary P trade?
Fischetti Gary P has filed SEC Form 4 disclosures for 1 company, including ANIK.
When was Fischetti Gary P's most recent SEC Form 4 filing?
Fischetti Gary P's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Fischetti Gary P's total buy and sell value in the current window?
Inside the rolling retention window, Fischetti Gary P bought $41K and sold $0 based on SEC Form 4 filings.
What was Fischetti Gary P's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000 ANIK shares on 2026-08-03, worth $21K, per SEC Form 4 filings.